Important notice

Unavailability of our Web site

We will be carrying a maintenance from 4:45 p.m. to 5:30 p.m. on December 8. Our website will be unavailable during this period. Thank you for your understanding.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4857 results found.

Example of search result explained

Pemazyre

Exceptional medication
  • Active ingredient(s):
    pemigatinib
  • Manufactured by:
    Incyte Corporation (Incyte)
  • Strength and dosage form:
    • Tablet 13.5 mg DIN : 2519968
    • Tablet 4.5 mg DIN : 2519933
    • Tablet 9 mg DIN : 2519941

Rystiggo

Exceptional medication
  • Active ingredient(s):
    rozanolixizumab
  • Manufactured by:
    U.C.B. Pharma Canada Inc. (U.C.B.)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 140 mg/mL (2 mL) DIN : 2556081

Xpovio

Exceptional medication
  • Active ingredient(s):
    selinexor
  • Manufactured by:
    Forus Therapeutics Inc. (Forus)
  • Strength and dosage form:
    Tablet 20 mg DIN : 2527677

Auro-Sitagliptin Hydrochloride et Metformin Hydrochloride

Exceptional medication
  • Active ingredient(s):
    sitagliptin/metformin hydrochloride
  • Manufactured by:
    Aurobindo Pharma Limited (Aurobindo)
  • Strength and dosage form:
    • Tablet 50 mg -1000 mg DIN : 2547821
    • Tablet 50 mg -500 mg DIN : 2547805
    • Tablet 50 mg -850 mg DIN : 2547813

Sandoz Tofacitinib

Exceptional medication
  • Active ingredient(s):
    tofacitinib citrate
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Tablet 10 mg DIN : 2551705
    • Tablet 5 mg DIN : 2551691

Otulfi

Exceptional medication
  • Active ingredient(s):
    ustekinumab (ulcerative colitis and Crohn's disease)
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114515
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114502
    • Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 99114503

Steqeyma

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis children)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114513
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114514
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114511

Otulfi

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2554283
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2554291
    • Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2554305

Zilbrysq

Exceptional medication
  • Active ingredient(s):
    zilucoplan
  • Manufactured by:
    U.C.B. Pharma Canada Inc. (U.C.B.)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 40 mg /mL (0,416 mL) DIN : 2549220
    • Subcutaneous Injectable Solution syringe 40 mg /mL (0,574 mL) DIN : 2549239
    • Subcutaneous Injectable Solution syringe 40 mg /mL (0,810 mL) DIN : 2549247

Pentasa

Covered
  • Active ingredient(s):
    5-aminosalicylic acid
  • Manufactured by:
    Ferring Inc. (Ferring)
  • Strength and dosage form:
    • Enteric Tablet 1 g DIN : 2399466
    • Enteric Tablet 500 mg DIN : 2099683
    • Suppository 1 g DIN : 2153564
Page 143 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.